Changing Oral Contraceptives from Prescription to Over-the-Counter Status: An Opinion Statement of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy

Changing Oral Contraceptives from Prescription to Over-the-Counter Status: An Opinion Statement of the Women's Health Practice and Research Network of the American College of Clinical Pharmacy
复制标题

DOI:
10.1592/phco.31.4.424
复制
发表时间:
2011-04-01
期刊:
影响因子:
4.1
通讯作者:
Besinque, Kathy
Besinque, Kathy
中科院分区:
医学2区
文献类型:
--
作者:
McIntosh, Jennifer;Rafie, Sally;Besinque, Kathy

文献摘要

被引文献

相似文献

解决意外怀孕问题是国家优先事项。减少意外怀孕的一项拟议战略是将口服避孕药改为非处方药,以改善口服避孕药的获得。现有数据表明口服避孕药符合非处方药产品要求的安全标准。现有文献表明,女性可以自我筛查口服避孕药的禁忌症,并且可以像临床医生一样做到这一点,OTC紧急避孕药的经验表明,OTC口服避孕药不会增加性冒险行为。妇女支持非处方药获得口服避孕药,但表示有兴趣获得药剂师咨询。根据这些数据,美国临床药学院妇女健康实践和研究网络支持在两个条件下将口服避孕药改为非处方药:在药剂师值班的地方出售,以及有通过医疗补助支付非处方药避孕药的机制。未来的研究应解决的问题,自付费用的个人,标签理解的研究,以及模式的药剂师报销的时间花在避孕咨询。
Addressing the issue of unintended pregnancy is a national priority. One proposed strategy to reduce unintended pregnancy is to improve access to oral contraceptives by changing them to over-the-counter (OTC) status. Existing data indicate that oral contraceptives meet safety criteria required of OTC products. Available literature demonstrates that women can self-screen for contraindications to oral contraceptives and can do this as well as clinicians, and experience with OTC emergency contraception suggests that OTC oral contraceptives would not increase sexual risk-taking behavior. Women support OTC access to oral contraceptives, but express an interest in accessing pharmacist counseling. On the basis of these data, the Women's Health Practice and Research Network of the American College of Clinical Pharmacy supports changing oral contraceptives to OTC status under two conditions: that they are sold where a pharmacist is on duty and that there are mechanisms in place to cover OTC contraceptives through Medicaid. Future research should address the issues of out-of-pocket costs to individuals, label-comprehension studies, and models for pharmacist reimbursement for time spent counseling on contraception.